166 related articles for article (PubMed ID: 33876249)
1. The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study.
Smigielski L; Wotruba D; Treyer V; Rössler J; Papiol S; Falkai P; Grünblatt E; Walitza S; Rössler W
Schizophr Bull; 2021 Aug; 47(5):1495-1508. PubMed ID: 33876249
[TBL] [Abstract][Full Text] [Related]
2. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
[TBL] [Abstract][Full Text] [Related]
3. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
[TBL] [Abstract][Full Text] [Related]
4. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.
Soliman A; O'Driscoll GA; Pruessner J; Holahan AL; Boileau I; Gagnon D; Dagher A
Neuropsychopharmacology; 2008 Jul; 33(8):2033-41. PubMed ID: 17957215
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
Berman BD; Hallett M; Herscovitch P; Simonyan K
Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
[TBL] [Abstract][Full Text] [Related]
7. The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [
Dahoun T; Nour MM; McCutcheon RA; Adams RA; Bloomfield MAP; Howes OD
Transl Psychiatry; 2019 Nov; 9(1):287. PubMed ID: 31712556
[TBL] [Abstract][Full Text] [Related]
8. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
9. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
[TBL] [Abstract][Full Text] [Related]
10. Reward motivation in humans and its relationship to dopamine D
Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
[TBL] [Abstract][Full Text] [Related]
11. Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.
Ledermann K; Jenewein J; Sprott H; Hasler G; Schnyder U; Warnock G; Johayem A; Kollias S; Buck A; Martin-Soelch C
Eur Neuropsychopharmacol; 2016 Feb; 26(2):320-330. PubMed ID: 26708319
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of extrastriatal [
Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Neuroimage; 2019 Nov; 202():116143. PubMed ID: 31473354
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
[TBL] [Abstract][Full Text] [Related]
14. Incentive motivation is associated with striatal dopamine asymmetry.
Tomer R; Goldstein RZ; Wang GJ; Wong C; Volkow ND
Biol Psychol; 2008 Jan; 77(1):98-101. PubMed ID: 17868972
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers.
Jangard S; Jayaram-Lindström N; Isacsson NH; Matheson GJ; Plavén-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Addiction; 2023 Jun; 118(6):1053-1061. PubMed ID: 36710462
[TBL] [Abstract][Full Text] [Related]
16. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
17. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
[TBL] [Abstract][Full Text] [Related]
18. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
[TBL] [Abstract][Full Text] [Related]
19. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.
Frank GK; Bailer UF; Henry SE; Drevets W; Meltzer CC; Price JC; Mathis CA; Wagner A; Hoge J; Ziolko S; Barbarich-Marsteller N; Weissfeld L; Kaye WH
Biol Psychiatry; 2005 Dec; 58(11):908-12. PubMed ID: 15992780
[TBL] [Abstract][Full Text] [Related]
20. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.
Arakawa R; Ito H; Takano A; Takahashi H; Morimoto T; Sassa T; Ohta K; Kato M; Okubo Y; Suhara T
Psychopharmacology (Berl); 2008 Apr; 197(2):229-35. PubMed ID: 18058087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
